FDA Approved Therapy for SOD1 Associated ALS
19:07 Share

Dr. Gordon Smith talks with Dr. Suma Babu about a newly approved treatment for ALS that is associated with a mutation in the superoxide dismutase 1 (SOD1) gene.

Read the related article on the FDA website). 

Disclosures can be found at Neurology.org)